Gemtesa’s manufacturer (Urovant Sciences) provides the Gemtesa Simple Savings Program. This is a financial assistance plan aimed at making Gemtesa (vibegron) — a treatment for overactive bladder in ...
NEW BRUNSWICK, N.J. — Drug maker Johnson & Johnson said Wednesday that patients applying for its HIV drug assistance program would have a more streamlined application process. The J&J Patient ...
Patient assistance programs and the 340B Drug Pricing Program promise to improve the financial stability, better serve vulnerable patients, and decrease the burden of cost for uninsured patients. Our ...
Key Enhancements Made to Gilead HIV Patient Assistance and Co-Pay Programs FOSTER CITY, Calif. & WASHINGTON, Jun 04, 2010 (BUSINESS WIRE) --Gilead Sciences and the ADAP Crisis Task Force (ACTF) today ...
Survey shows more than one third of uninsured, unemployed Americans have skipped or incorrectly taken their prescribed medications to save money, yet many may qualify for free medicine WHITEHOUSE ...
On January 15, 2025, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 25-01, a favorable opinion analyzing a pharmaceutical manufacturer’s ...
One of the most powerful components of the Affordable Care Act (ACA) was the mandate that nonprofit hospitals provide an income-based financial assistance program. But 10 years after the passage of ...
Pharmaceutical companies are taking a lot of reflected heat in the uproar over the 5,000% price hike for a drug needed by AIDS patients. But so far, the industry’s method of making sure that ...
The Department of Health and Human Services Office of Inspector General (OIG) has issued a long-awaited, favorable advisory opinion regarding certain single-donor rare disease state patient assistance ...
Families whose household income was equal to or less than 350% of the federal poverty guidelines are eligible for aid. Norton Healthcare—a Louisville, Kentucky-based healthcare provider with over 340 ...
Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study One potential solution to ease the ...
AbbVie is facing a lawsuit from a pharmaceutical assistance company stemming from the drugmaker discouraging patients and employers from doing business with the company and naming it in a lawsuit in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback